Today's Pollen Forecast for 07981 :

Pollen Forecast 07981 :

LOW

The Clear Choice of Claritin®: Non-drowsy Allergy Relief1

Nose icon showing airflow - improves nasal airflow 2x more

*As demonstrated in a clinical trial, based on peak intake after the first dose vs fluticasone propionate 50 mcg nasal spray (2 sprays per nostril).

TRUST THE HERITAGE OF CLARITIN® IN TREATING ALLERGIC RHINITIS

#1 Doctor Recommended

Claritin® is the #1 doctor recommended OTC brand of non-drowsy adult oral antihistamines12

#1 worldwide icon

Claritin® is the world’s best-selling non-prescription allergy remedy12

Clinically proven icon

Approximately 90,000 subjects aged 12 years and older have been treated with loratadine (10 mg, once daily) in controlled and uncontrolled clinical trials14

several versions of Claritin products neatly arranged

CLARITIN® SAMPLES & COUPONS

Claritin® offers allergy relief for kids and adults in a variety of forms and flavors.

Help your patients tackle their tough allergy symptoms with samples and coupons for Claritin® products.

References: 1. Claritin® Drug Facts. NDA019658. 2. Ramaekers JG, Uiterwijk MMC, O’Hanlon JF. Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving. Eur J Clin Pharmacol. 1992;42(4):363-369. 3. Verster JC, Volkerts ER.  Antihistamines and driving ability: evidence from on-the-road driving studies during normal traffic. Ann Allergy Asthma Immunol. 2004;92(3):294-303. doi:10.1016/S1081-1206(10)61566-9 4. Popescu F-D. H1 antihistamines and driving. J Med Life. 2008;1(3):262-268. 5. Federal Aviation Administration. What over-the-counter (OTC) medications can I take and still be safe to fly? Accessed August 4, 2021. https://www.faa.gov/licenses_certificates/medical_certification/media/OTCMedicationsforPilots.pdf 6. Kay GG, Harris AG. Loratadine: a non-sedating antihistamine. Review of its effects on cognition, psychomotor performance, mood and sedation. Clin Exp Allergy. 1999;29 Suppl 3:147-150. doi:10.1046/j.1365-2222.1999.0290s3147.x 7. Kaiser HB, Gopalan G, Chung W. Loratadine provides early symptom control in seasonal allergic rhinitis. Allergy Asthma Proc. 2008;29:654-658. 8. Philip G, Malstrom K, Hampel Jr. FC, et al. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. Clin Exp Allergy. 2002;32(7):1020-1028. 9. Claritin-D® 12 Hour Drug Facts. NDA019670. 10. Georgitis JW, Meltzer EO, Kaliner M, Weiler J, Berkowitz R. Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge. Ann Allergy Asthma lmmunol. 2000;84(4):451-459. 11. Children’s Claritin® Chewables Drug Facts. NDA021891. 12. Data on file. Bayer Pharmaceuticals. 13. Ng CC, Romaikin D, Steacy LM, et al. Comparative nasal airflow with loratadine-pseudoephedrine and fluticasone nasal spray for allergic rhinitis. Ann Allergy Asthma Immunol. 2021;S1081-1206(21)00348-3. doi:10.1016/j.anai.2021.05.001 14. Claritin®. Prescribing information. Schering Corporation; 2000.